MedCity News

Paper Cut Craft of Human Brain Regions Side View Anatomy Diagram on Beige Background.

Startups, Devices & Diagnostics Health Tech,

French Startup Gains FDA Clearance for First In‑Ear EEG Device

By Katie Adams

Consumer / Employer, Health Tech

Angle Health, Leap Health Team Up to Bring More Affordable Infusion Care to Employers

Angle Health and Leap Health partnered to offer more affordable, at-home infusion care to small employers.

By Marissa Plescia

BioPharma

UPMC Enteprises’ Biopharma Lead: We are At a Tipping Point When it Comes to China

Matthias Kleinz, executive vice president and head of translational sciences investments at UPMC Enterprises, explained why biopharma companies cannot ignore China anymore.

By Arundhati Parmar

BioPharma, Pharma

GSK Grows in Immunology, Buying Rapt Therapeutics and Food Allergy Drug in $2.2B Deal

Rapt Therapeutics brings to GSK ozureprubart, a long-acting antibody that inhibits the validated immunology target immunoglobulin E (IgE). If GSK is able to bring this drug to the market, it would complete with the blockbuster Genentech and Novartis allergy drug Xolair.

By Frank Vinluan

Latest Video

Latest News

MedCity Influencers

Reading Between the Lines of the New Dietary Guidelines

From the heavy emphasis on limiting all ultra-processed foods and eliminating added sugars to placing saturated fats at the top of the pyramid, the new DGAs provide a framework, but highlight areas that still need nuance, clarity, and practical context.

By Gretchen Zimmermann

MedCity Influencers

Bundle of dollars getting cut into various sizes, funding cut, Medicaid cuts

Navigating Uncertainty: Hospitals Confront Medicaid Cuts

Hospitals have an opportunity to make strategic changes now that can better position both their organizations and their patients for what’s ahead. Here’s what to expect and where to focus next.

By Itzik Cohen

Health Tech

Wellcome Leap and Medicines360 Partner to Advance Maternal Health Tools Globally

Wellcome Leap and Medicines360 have partnered to develop affordable tools to detect pregnancy complications earlier and reduce stillbirths worldwide.

By Marissa Plescia

BioPharma, Startups, Devices & Diagnostics

JPM Deals Recap: Boston Scientific Acquisition, a Mega Round for Parabilis, Enodia Emerges & More

Cancer drugs are always popular biotech investments, but autoimmune disease also figures prominently in the startup financings announced during the annual J.P. Morgan Healthcare Conference this year.

By Frank Vinluan

MedCity Influencers

TEAM Success Depends on How Well a Hospital Ensures Medicare Patients Get the 30-Day Episode of Care They Need

A unified workflow for all referrals, resulting in fewer clicks and less confusion, means provider matching can be conducted based on specialty, location, insurance, and real-time availability, for an easier track to the right provider, not just any provider.

By Kevin Healy

MedCity Influencers

10 Key MedTech Themes for 2026

In today's dynamic environment, companies are navigating deal-making and innovation spurred by the vertical integration of AI and a rebounding IPO market. Here are ten global trends poised to define the industry in the coming year.

By Vinita Kailasanath, Kayla Weston, Yungjee Kim and Shannon O’Hara

Opinion

The Pill Patients Saved

It reduced cravings, dulled alcohol’s “buzz,” and carried no risk of addiction. By every measure, naltrexone should have immediately become a major triumph. Instead, it flopped because the institutions charged with treating addiction refused to use it. Now considered a gold standard, it survived because patients and communities kept it alive.

By Dr. Joseph R Volpicelli

MedCity Influencers

Personal Touch Drives More Meaningful Member Engagement than Tech-Only

Programs that combine personal outreach with smart use of technology close more care gaps, improve quality measures, build member loyalty and improve retention.

By Dan McDonald

MedCity Influencers

Bridging the Diagnostic Gap in Allergy Care

By getting to the root cause of patients’ allergies with detailed symptom histories from patients coupled with history, informed comprehensive allergy testing can help uncover hidden allergies, ensure both effective care and smarter resource utilization, and improve patient safety.

By Gary Falcetano

Startups, BioPharma, Health Tech Artificial Intelligence,

A pattern of megaphones with one megaphone facing in the opposite direction to the rest. A Composite image made of photographic textures and drawn elements

6 JPM Announcements You Don’t Want to Miss

This year's J.P. Morgan Healthcare Conference brought a slew of news announcements — from acquisitions to partnerships to new products and more. This list compiles short summaries for six of the event’s most notable announcements.

By Katie Adams

Policy, Payers

Trump’s ‘Great Healthcare Plan’ Aims to Cut Costs, but Details Are Sparse, Execs Say

President Donald Trump unveiled the Great Healthcare Plan to lower drug costs and insurance premiums, but healthcare executives say the proposal lacks sufficient detail to assess whether it would meaningfully reduce costs.

By Marissa Plescia

Startups, BioPharma

Novo Nordisk Foundation Commits Up to $850M to Boost European Innovation

BioInnovation Institute, which has supported 131 startups in Denmark to date, will use the new funding to expand its reach to startups across Europe. This innovation engine spun out of the Novo Nordisk Foundation in 2020.

By Frank Vinluan

What Merck’s Chief Medical Officer Thinks of Lilly’s Approach to GLP-1s

Eliav Barr gave kudos to Eli Lilly for testing the company's Zepbound weight loss drug in combination with a psoriatic arthritis drug to achieve better results for the underlying inflammation.

By Arundhati Parmar